Seeing Is Believing
PSTV is currently covered by 5 analysts with an average price target of $-1382.98. This is a potential upside of $-1383.77 (-175160.76%) from yesterday's end of day stock price of $0.79.
Plus Therapeutics's activity chart (see below) currently has 12 price targets and 27 ratings on display. The stock rating distribution of PSTV is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 36.67% with an average time for these price targets to be met of 237.2 days.
Highest price target for PSTV is $9, Lowest price target is $5.5, average price target is $8.83.
Most recent stock forecast was given by JASON KOLBERT from DAWSON JAMES on 28-Mar-2025. First documented stock forecast 28-Jun-2016.
Currently out of the existing stock ratings of PSTV, 14 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$9
$7.84 (675.86%)
$9
29 days ago
(28-Mar-2025)
2/6 (33.33%)
$7.84 (675.86%)
67
Buy
$5.5
$4.34 (374.14%)
29 days ago
(28-Mar-2025)
0/4 (0%)
$4.34 (374.14%)
Buy
4 months 17 days ago
(09-Dec-2024)
1/2 (50%)
$35.7 (90.84%)
831
Buy
$12
$10.84 (934.48%)
$90
1 years 11 months 23 days ago
(03-May-2023)
0/2 (0%)
$8.25 (220.00%)
Buy
$8250
$8248.84 (711106.88%)
8 years 9 months 29 days ago
(28-Jun-2016)
1/1 (100%)
$-6975 (-45.81%)
288
What is PSTV (Plus Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on PSTV (Plus Therapeutics) with a proven track record?
Which analyst has the current lower performing score on PSTV (Plus Therapeutics) with a proven track record?
Which analyst has the most public recommendations on PSTV (Plus Therapeutics)?
Which analyst is the currently most bullish on PSTV (Plus Therapeutics)?
Which analyst is the currently most reserved on PSTV (Plus Therapeutics)?